For example, Poletti et al. used a IL-2Rγ−/− Rag2−/− mouse model as preclinical model for a gene therapy for X-linked SCID (SCID-X1) patients [154]. The gene discussed is IL2RG; the disease is T-B+ severe combined immunodeficiency due to gamma chain deficiency.